Hospital Burden of Bone Metastases in Cancer Patients
Author Information
Author(s): Pockett R.D., Castellano D., McEwan P., Oglesby A., Barber B.L., Chung K.
Primary Institution: Cardiff Research Consortium, the MediCentre, Cardiff, UK
Hypothesis
What is the hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast, lung, or prostate cancer in Spain?
Conclusion
Cancer patients consume progressively more hospital resources as bone metastases and subsequent skeletal-related events develop.
Supporting Evidence
- 9.5% of breast cancer patients developed bone metastases within 3 years.
- 15.6% of lung cancer patients developed bone metastases within 3 years.
- 16.6% of prostate cancer patients developed bone metastases within 3 years.
- Patients with MBD had a greater mean number of re-admissions than those with cancer only.
- The average cost of the index admission increased as the disease progressed.
Takeaway
When cancer spreads to the bones, patients need more hospital care and stay longer, which costs more money.
Methodology
Data from the IASIST hospital activity database was analyzed for patients with breast, lung, or prostate cancer admitted between 2003 and 2006.
Potential Biases
There is a risk of underestimating the true incidence and costs of cancer care due to incomplete data from other healthcare settings.
Limitations
The study may have inaccuracies due to potential miscoding in the database and does not include patient mortality data.
Participant Demographics
Patients included were those with breast cancer (n=10090), lung cancer (n=10526), and prostate cancer (n=7546).
Statistical Information
Confidence Interval
95% CI for incidence rates provided.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website